dronabinol has been researched along with Dementia in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Bagetta, G; Boccella, S; Corasaniti, MT; Guida, F; Luongo, L; Maione, S; Nicotera, P; Scuteri, D; Tonin, P | 1 |
| Hernandez, C; Laiteerapong, N; Sawicki, SM; Zahradnik, EK | 1 |
| Ellison, JM; Forester, BP; Harper, DG; Stolyar, A; Woodward, MR | 1 |
| Ahmed, AI; Burger, DM; Colbers, A; Kramers, C; Olde Rikkert, MG; van den Elsen, GA; van der Marck, MA | 1 |
| Ahmed, AI; Feuth, T; Kramers, C; Olde Rikkert, MG; Rosenberg, PB; van den Elsen, GA; van der Marck, MA; Verkes, RJ | 1 |
| Ahmed, AIA; Feuth, T; Olde Rikkert, MGM; van den Elsen, GAH; van der Marck, MA; Verkes, RJ | 1 |
| Ahmed, AI; Kramers, C; Marijnissen, RM; Olde Rikkert, MG; Tobben, L; van den Elsen, GA; van der Marck, MA; Verkes, RJ | 1 |
| Cairns, R; Howard, R; Krishnan, S | 1 |
| Homan, P; Schüpbach, B; Seifritz, E; Strik, W; Walther, S | 1 |
| Eichmann, U; Kunz, D; Mahlberg, R; Walther, S | 1 |
| Mahlberg, R; Walther, S | 1 |
1 review(s) available for dronabinol and Dementia
| Article | Year |
|---|---|
Cannabinoids for the treatment of dementia.
Topics: Alzheimer Disease; Cannabinoids; Dementia; Dronabinol; Humans; Psychotropic Drugs | 2009 |
8 trial(s) available for dronabinol and Dementia
| Article | Year |
|---|---|
NAbiximols Clinical Translation To the treatment of Pain and Agitation In Severe Dementia (NACTOPAISD): Clinical trial protocol.
Topics: Aged; Cannabidiol; Chronic Pain; Dementia; Double-Blind Method; Dronabinol; Drug Combinations; Humans; Oral Sprays; Psychomotor Agitation; Randomized Controlled Trials as Topic | 2022 |
Safety, pharmacodynamics, and pharmacokinetics of multiple oral doses of delta-9-tetrahydrocannabinol in older persons with dementia.
Topics: Aged; Aged, 80 and over; Blood Pressure; Cross-Over Studies; Dementia; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Female; Frail Elderly; Hallucinogens; Heart Rate; Humans; Male | 2015 |
Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trial.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Aggression; Cannabinoid Receptor Agonists; Dementia; Double-Blind Method; Dronabinol; Humans; Male; Psychomotor Agitation; Quality of Life; Treatment Outcome | 2015 |
Tetrahydrocannabinol in Behavioral Disturbances in Dementia: A Crossover Randomized Controlled Trial.
Topics: Aged; Cross-Over Studies; Dementia; Double-Blind Method; Dronabinol; Female; Humans; Male; Mental Disorders; Netherlands; Psychotropic Drugs; Treatment Outcome | 2015 |
Effects of tetrahydrocannabinol on balance and gait in patients with dementia: A randomised controlled crossover trial.
Topics: Aged; Cross-Over Studies; Dementia; Double-Blind Method; Dronabinol; Female; Gait; Humans; Male; Postural Balance; Posture | 2017 |
Randomized, controlled crossover trial of dronabinol, 2.5 mg, for agitation in 2 patients with dementia.
Topics: Aged; Aged, 80 and over; Akathisia, Drug-Induced; Cross-Over Studies; Dementia; Dronabinol; Humans; Male; Psychomotor Agitation | 2011 |
Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Dementia, Vascular; Dronabinol; Electroencephalography; Female; Hallucinogens; Humans; Male; Motor Activity; Pilot Projects; Psychomotor Agitation; Sleep Wake Disorders | 2006 |
Actigraphy in agitated patients with dementia. Monitoring treatment outcomes.
Topics: Aged; Aged, 80 and over; Dementia; Dronabinol; Female; Humans; Male; Melatonin; Middle Aged; Monitoring, Ambulatory; Motor Activity; Outcome Assessment, Health Care; Psychomotor Agitation; Psychotropic Drugs; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2007 |
2 other study(ies) available for dronabinol and Dementia
| Article | Year |
|---|---|
The Use of Dispensary-Obtained Tetrahydrocannabinol as a Treatment for Neuropsychiatric Symptoms of Dementia.
Topics: Aged; Antipsychotic Agents; Anxiety; Anxiety Disorders; Dementia; Dronabinol; Humans | 2023 |
Dronabinol for the treatment of agitation and aggressive behavior in acutely hospitalized severely demented patients with noncognitive behavioral symptoms.
Topics: Aggression; Anorexia; Antidepressive Agents; Antipsychotic Agents; Cannabinoid Receptor Agonists; Cholinesterase Inhibitors; Cohort Studies; Dementia; Dronabinol; Drug Therapy, Combination; Female; Hospitalization; Humans; Male; Mental Disorders; Psychomotor Agitation; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2014 |